Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT06232096 Recruiting - Clinical trials for Relapsed or Refractory Multiple Myeloma

A Study of MBS314 in Participants With Relapsed/Refractory Multiple Myeloma.

Start date: February 22, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Phase I/Ⅱ, multicenter, open-label, dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics(PD) and efficacy of a novel asymmetric trivalent tri-specific humanized antibody, MBS314, administered by intravenous (IV) infusion in participants with relapsed or refractory multiple myeloma. This entry-to-human study is divided in 2 parts: a dose escalation part (Phase Ⅰa) and an expansion part (Phase Ⅰb/Ⅱ).

NCT ID: NCT06231381 Recruiting - Clinical trials for Generalized Pustular Psoriasis (GPP)

Efficacy and Safety of HB0034 in Patients With Generalized Pustular Psoriasis (GPP)

Start date: February 29, 2024
Phase: Phase 2
Study type: Interventional

This is a phase II, multicenter, double-blind, randomized, placebo parallel-controlled clinical trial to evaluate the efficacy and safety of HB0034 in patients with generalized pustular psoriasis (GPP) presenting with an acute flare of moderate to severe intensity.

NCT ID: NCT06230328 Recruiting - Clinical trials for Hepatocellular Carcinoma

Brazilian Reality of Hepatocellular Carcinoma

BRA-HEP
Start date: April 15, 2024
Phase:
Study type: Observational

National, multicenter, retrospective, non-randomized observational study (Real World Evidence-RWE) with the purpose of analyzing the epidemiological profile of Hepatocellular Carcinomas (BCLC A, B or C), clinical management, progression profile and overall survival of castrated patients treated in national oncology care reference centers, within the last 6 years (between 2017 to 2022).

NCT ID: NCT06230263 Recruiting - Clinical trials for Comparative Effectiveness Research

Comparative Functional Vision Outcomes: DAILIES TOTAL1 Toric vs. Spherical Lenses in Asian Astigmatic Patients

Start date: December 30, 2023
Phase: N/A
Study type: Interventional

The goal of this comparative clinical trial is to assess the effectiveness of DAILIES TOTAL1 Toric Contact Lenses compared to Spherical Equivalent Contact Lenses in improving the functional vision of astigmatic patients, with a particular focus on Asian individuals who frequently use digital devices. The main questions it aims to answer are: How do DAILIES TOTAL1 Toric Contact Lenses affect the quality of vision in daily activities, especially when using digital screens, compared to Spherical Equivalent Contact Lenses? What is the level of comfort and overall satisfaction among participants using DAILIES TOTAL1 Toric Contact Lenses versus those using Spherical Equivalent Contact Lenses? Participants will be asked to wear both types of contact lenses for a specified period. During this time, they will perform various tasks involving digital screens. Their vision quality and comfort levels will be monitored and recorded. They will also be asked to report their satisfaction with each type of lens and any differences in their experience with screen use.

NCT ID: NCT06230185 Recruiting - Clinical trials for Minimal Residual Disease

ctDNA Based MRD Testing for NAC Monitoring in TNBC

B-STRONGER-I
Start date: November 9, 2023
Phase:
Study type: Observational

A prospective, multicenter, observational study to evaluate the correlation of Molecular Residual Disease (MRD) detection using circulating tumor DNA guided test to pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) in stage I-III triple negative breast cancer (TNBC). Results from this study aim to improve MRD detection and disease outcomes for future patients.

NCT ID: NCT06230159 Recruiting - Clinical trials for Cigarette Smoking-Related Carcinoma

Evaluating the Impact of Synthetic Cooling Agents in Combustible Cigarettes on Smoking Perceptions and Use

Start date: November 28, 2023
Phase: N/A
Study type: Interventional

This clinical trial evaluates the impact of synthetic cooling agents in combustible cigarettes on smoking perceptions and use. Menthol, a natural chemical, is a cooling agent that increases nicotine dependence among smokers. Menthol cigarettes largely contribute to the huge burden that smoking puts on public health. Approximately 43% of adult smokers smoke menthol cigarettes. Regulatory agencies have begun a ban on menthol. In response to the ban, the tobacco industry has introduced synthetic cooling agents as a flavorless replacement to provide the same cooling effects as menthol. Information gained from this trial may help researchers determine how the addition of synthetic cooling agents changes the appeal, abuse liability potential, and respiratory toxicity profile of combustible cigarettes.

NCT ID: NCT06230081 Recruiting - Clinical trials for Osteoarthritis of the Knee or Hip

Comparison Between Blocks or Not in Joint Arthroplasty

BLAST
Start date: February 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect on postoperative pain, opioid consumption and function by adding a combination of regional blocks with local anaesthetic before total hip- and knee arthroplasty compared to standard pain management strategies.

NCT ID: NCT06229925 Recruiting - Clinical trials for Transcranial Direct Current Stimulation

Effects of Transcranial Direct Current Stimulation Versus Sham in Subacromial Pain Syndrome

Start date: March 4, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of applying Transcranial direct current stimulation on pain levels and function, quality of life, muscle strength and range of motion in individuals with subacromial pain syndrome.

NCT ID: NCT06229886 Recruiting - Clinical trials for Tricuspid Regurgitation

Effect of PEEP on TRJV in Mechanically Intubated Pediatric Patients

Start date: December 6, 2023
Phase: N/A
Study type: Interventional

Prospective observational cohort study within the Pediatric Intensive Care Unit (PICU). We will perform point-of-care-ultrasound (POCUS) to quantify tricuspid regurgitant jet velocity (TRJV) on mechanically ventilated (MV) children. Mechanically ventilated (MV) children approaching extubation as per the discretion of the PICU clinical team will undergo a positive end expiratory pressure (PEEP) titration protocol in a safe and timely manner in the PICU. During this PEEP titration, POCUS will be performed by a pediatric intensivist and interpreted by a pediatric cardiologist. Medical demographics will be collected from the electronic medical record and recorded.

NCT ID: NCT06229860 Recruiting - Clinical trials for Chronic Myeloid Leukemia

Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia

Start date: January 25, 2024
Phase:
Study type: Observational

This is an observational pilot study to examine the association between a patient's personality and adherence to tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.